LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Market By Drugs & Devices And Geography | Forecast 2019- 2027

Request Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton Market Research, the market for ophthalmology drugs and devices in Latin America is expected to burgeon with a CAGR of 5.31% in the forecast period 2019-2027.

The countries that have been considered in the Latin America ophthalmology drugs and devices market are:

•           Mexico

•           Brazil

•           Rest of Latin America

The Latin America ophthalmology drugs and devices market is precisely driven owing to the escalating prevalence of diabetes, along with the increasing healthcare expenditure, mainly in the countries of Brazil and Argentina. Brazil is spending a massive amount of capital in the healthcare sector, in purchasing new devices and instruments. According to the International Trade Administration, public and private healthcare expense in Brazil amounts to around 9.6% of the GDP. Out of this sum, about $10.4 billion was accounted to purchase of medical equipment and devices, paving the growth & adoption of the ophthalmological drugs and devices market in the country. Diabetes causes a direct impact on the eyes. Although a large number of non-diabetic people get cataracts, people having diabetes have 60% more chances of developing this eye condition, that too, at a younger age and have it develop at a faster rate. In addition, as per the World Health Organization, the healthcare expenditure in Argentina accounted for about 7% of the GDP in 2015. In 2015, according to the World Economic Forum, 22.5% of the total expenditure by the Argentinian government was towards healthcare, which is further augmenting the growth of the ophthalmology drugs and devices market in the Latin American region.

Novartis International AG is a Switzerland-based multinational pharmaceutical company. The company majorly manufactures products related to generic drugs, pharmaceuticals, OTC drugs, vaccines, diagnostics, animal health products, contact lenses, etc. The company has its global footprint in more than 155 countries, including Argentina, Brazil, Canada, China, Hong Kong, India, Russia, Spain, the UK, the US, Italy, etc. The company had accounted for a total revenue share worth $48.5 billion in 2016.

Related Reports

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027
Lifesciences

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027

Market By Offerings, Technolog ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027
Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027

Market By Therapeutics & Diagn ..

VIEW REPORT
ASIA-PACIFIC BIOSURGERY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BIOSURGERY MARKET 2019-2027

Market By Product, Application ..

VIEW REPORT
ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Applicat ..

VIEW REPORT
ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027

Market By Test Types, Technolo ..

VIEW REPORT
ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027

Market By Component, End-user ..

VIEW REPORT
ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027

Market By Age Group, Education ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1.   BARGAINING POWER OF BUYERS

2.2.2.   BARGAINING POWER OF SUPPLIER

2.2.3.   THREATS OF NEW ENTRANTS

2.2.4.   THREATS OF SUBSTITUTES

2.2.5.   COMPETITIVE RIVALRY

2.3. STRATEGIC OUTLOOK

2.4. KEY INSIGHT

2.5. VALUE CHAIN OUTLOOK

2.6. KEY BUYING STANDARDS

2.7. INVESTMENT OUTLOOK

2.8. SUPPLY CHAIN OUTLOOK

2.9. MARKET DRIVERS

2.9.1.   INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR

2.9.2.   UPSURGE IN HEALTHCARE SPENDING

2.9.3.   TECHNOLOGICAL ADVANCEMENT

2.10.            MARKET RESTRAINTS

2.10.1.                EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY

2.10.2.                LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS

2.10.3.                DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE

2.11.            MARKET OPPORTUNITIES

2.11.1.                DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES IS INCREASING

2.12.            MARKET CHALLENGES

2.12.1.                DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES

3.    OPHTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES

3.1. DEVICES

3.1.1.   DIAGNOSTIC & MONITORING EQUIPMENT

3.1.1.1.      OPTICAL COHERENCE TOMOGRAPHY

3.1.1.2.      OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

3.1.1.3.      FUNDUS CAMERA MARKET

3.1.1.4.      OPHTHALMOSCOPES

3.1.1.5.      RETINOSCOPE

3.1.1.6.      PACHYMETER

3.1.1.7.      WAVEFRONT ABERROMETERS

3.1.1.8.      PERIMETERS/VISUAL FIELD ANALYZER

3.1.1.9.      AUTOREFRACTORS/PHOROPTER

3.1.1.10.   SPECULAR MICROSCOPE

3.1.1.11.   CORNEAL TOPOGRAPHERS

3.1.1.12.   OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET

3.1.2.   SURGERY DEVICES

3.1.2.1.      CATARACT SURGERY DEVICES

3.1.2.2.      GLAUCOMA SURGERY DEVICES

3.1.2.3.      REFRACTIVE SURGERY DEVICES

3.1.2.4.      VITREORETINAL SURGERY DEVICES

3.2. VISION CARE

3.3. DRUGS

3.3.1.   GLAUCOMA DRUG

3.3.2.   RETINAL DISORDER DRUG

3.3.3.   DRY EYE DRUG

3.3.4.   ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG

3.3.5.   DRUGS BY USE OF PRESERVATION

3.3.5.1.      PRESERVED DRUGS

3.3.5.2.      PRESERVATIVE FREE DRUGS

4.    OPHTHALMOLOGY DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK

4.1.1.   BRAZIL

4.1.2.   MEXICO

4.1.3.   REST OF LATIN AMERICA

5.    COMPETITIVE LANDSCAPE

5.1. ALLERGAN, INC.

5.2. BAYER

5.3. CARL ZEISS AG

5.4. ESSILOR INTERNATIONAL S.A.

5.5. GLAXOSMITHKLINE

5.6. JOHNSON & JOHNSON, INC.

5.7. NOVARTIS INTERNATIONAL AG

5.8. PFIZER

5.9. ROCHE HOLDING AG

5.10.            SANTEN PHARMACEUTICAL CO., LTD.

6.    METHODOLOGY AND SCOPE

6.1. RESEARCH SCOPE

6.2. SOURCES OF DATA

6.3. RESEARCH METHODOLOGY

List of table

TABLE 1        LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 2        COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY

TABLE 3        SELECTED LISTS OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS

TABLE 4        LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 5        LATIN AMERICA DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT  BY TYPES 2019-2027 ($ MILLION)

TABLE 6        LATIN AMERICA DEVICES MARKET IN SURGERY DEVICE BY TYPES 2019-2027 ($ MILLION)

TABLE 7        LATIN AMERICA DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2019-2027 ($ MILLION)

TABLE 8        LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

FIGURE 2      LATIN AMERICA DRUGS AND DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)

FIGURE 3      LATIN AMERICA DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 4      LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2019-2027 ($ MILLION)

FIGURE 5      LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 6      LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027 ($ MILLION)

FIGURE 7      LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($ MILLION)

FIGURE 8      LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($ MILLION)

FIGURE 9      LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($ MILLION)

FIGURE 10   LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2019-2027 ($ MILLION)

FIGURE 11   LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2019-2027 ($ MILLION)

FIGURE 12   LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2019-2027 ($ MILLION)

FIGURE 13   LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027 ($ MILLION)

FIGURE 14   LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027 ($ MILLION)

FIGURE 15   LATIN AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2019-2027 ($ MILLION)

FIGURE 16   LATIN AMERICA DEVICES MARKET IN SURGERY DEVICE 2019-2027 ($ MILLION)

FIGURE 17   LATIN AMERICA SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 18   LATIN AMERICA SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 19   LATIN AMERICA SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 20   LATIN AMERICA SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)

FIGURE 21   LATIN AMERICA DEVICES MARKET IN VISION CARE MARKET 2019-2027 ($ MILLION)

FIGURE 22   LATIN AMERICA DRUGS AND DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)

FIGURE 23   LATIN AMERICA DRUGS MARKET IN GLAUCOMA DRUG 2019-2027 ($ MILLION)

FIGURE 24   LATIN AMERICA DRUGS MARKET IN RETINAL DISORDER DRUG 2019-2027 ($ MILLION)

FIGURE 25   LATIN AMERICA DRUGS MARKET IN DRY EYE DRUG 2019-2027 ($ MILLION)

FIGURE 26   LATIN AMERICA DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2019-2027 ($ MILLION)

FIGURE 27   LATIN AMERICA DRUGS BY USE OF PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)

FIGURE 28   LATIN AMERICA DRUGS BY USE OF PRESERVATION IN PRESERVATION-FREE DRUGS 2019-2027 ($ MILLION)

FIGURE 29   LATIN AMERICA PRESERVATION-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)

FIGURE 30   LATIN AMERICA PRESERVATION-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)

FIGURE 31   LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 32   BRAZIL COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 33   MEXICO COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 34   REST OF LATIN AMERICA COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;